← Open Payments lookup

SURAYYO BOBODZHANOVA: Open Payments

NPI 1730450578 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$781 in 11 payments from 8 companies in 2025. Trend: 2023 $1,048 · 2024 $290 · 2025 $781

Food & beverage: $781
CompanyPaymentsAmount
E.R. Squibb & Sons, L.L.C.4$199
Teva Pharmaceuticals USA, Inc.1$133
Alkermes, Inc.1$130
Vanda Pharmaceuticals Inc.1$125
Supernus Pharmaceuticals, Inc.1$124
Daiichi Sankyo Inc.1$28
AstraZeneca Pharmaceuticals LP1$24
Caris MPI, Inc.1$18

Products named: AUSTEDO XR, LYBALVI, FANAPT, COBENFY, Qelbree, Enhertu, LYNPARZA, OPDIVO.

Industry payments across TX — which companies pay providers there.